News
Videos
Conferences
Events
Resources
Subscribe

|Videos|January 20, 2016

Receiving a Second Opinion

Episodes in this series

EP. 1 Treatment Options and Challenges for Patients With Pancreatic Cancer

EP. 1 Treatment Options and Challenges for Patients With Pancreatic Cancer

EP. 2 A Promising Future for Pancreatic Cancer

EP. 2 A Promising Future for Pancreatic Cancer

EP. 3 Pancreatic Cancer: David's Story to Remission

EP. 3 Pancreatic Cancer: David's Story to Remission

EP. 4 Pancreatic Cancer: Donald's Story

EP. 4 Pancreatic Cancer: Donald's Story

EP. 5 Locating Support Resources for Patients

EP. 5 Locating Support Resources for Patients

EP. 6 Treatment Considerations for Patients Researching Their Options

EP. 6 Treatment Considerations for Patients Researching Their Options

EP. 7 Moving Forward With Pancreatic Cancer

EP. 7 Moving Forward With Pancreatic Cancer

EP. 8 Receiving a Second Opinion

EP. 8 Receiving a Second Opinion

EP. 9 Maintenance Therapy: What to Expect

EP. 9 Maintenance Therapy: What to Expect

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Natalie S. Berger

Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

December 31st 2025

Image of ribbon.

Gedatolisib Plus Faslodex Shows Efficacy in Advanced HR+ Breast Cancer

December 30th 2025

Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!

Reading the Fine Print: Why Ingredient Awareness Matters After Cancer

December 30th 2025

Ribbons.

Piqray Plus Faslodex Improves PFS in Advanced Breast Cancer

December 29th 2025

Dr. Roshani Patel answers questions from patients with breast cancer on Keytruda-induced colitis, sugar intake during chemo, and how to stay active.

Addressing Concerns on Diet During Breast Cancer Treatment

December 29th 2025

Trending on CURE

Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CAR-T Therapy Helps Manhattan Attorney Achieve Complete Response For NSCLC

Early Data Show INCA033989 Activity in Calreticulin-Driven Myelofibrosis

Reading the Fine Print: Why Ingredient Awareness Matters After Cancer

Rusfertide Maintains Hematocrit Control in Patients With Polycythemia Vera